Company: CGC
Filing Date: 2025-05-29
Form Type: POSASR
Source: 0001104659-25-054285
Chunk: 81

Company: Canopy Growth Corp
Filing Date: 2025-05-29
Form: POSASR
Chunk 81
---
 business, financial condition or results of operations could be materially adversely affected by any of these risks. The trading price of our Common Shares could decline due to any of these risks, and you may lose all or part of your investment. Please also read carefully the sections titled “Special Note Regarding Forward-Looking Statements; Risk Factor Summary” in our most recent Annual Report on Form 10-K.

<div align='center'>3</div>

TABLE OF CONTENTS

### THE COMPANY
We are a world-leading cannabis company which produces, distributes, and sells a diverse range of cannabis and cannabis-related products. Our cannabis products are principally sold for adult-use and medical purposes under a portfolio of distinct brands in Canada pursuant to the Cannabis Act , SC 2018, c 16, and globally pursuant to applicable international and Canadian legislation, regulations, and permits. Our core operations are in Canada, Germany and Australia.

The Company’s principal executive offices are located at 1 Hershey Drive, Smiths Falls, Ontario, K7A 0A8. Our Common Shares are listed for trading on the TSX under the symbol “WEED” and Nasdaq under the symbol “CGC.” The Company maintains a website at www.canopygrowth.com . The information on, or otherwise accessible through, our website does not constitute a part of, and is not incorporated by reference into, this prospectus.

<div align='center'>4</div>

TABLE OF CONTENTS

### USE OF PROCEEDS
We will receive no proceeds from the sale of the Shares by the Selling Securityholders. We would, however, receive proceeds upon the exercise of the September 2023 Warrants, the January 2024 Warrants, the May 2024 Warrants and the Put Warrants (collectively, the “Warrants”) held by certain of the Selling Securityholders which, if such Warrants are exercised in full for cash, would be approximately US$110.5 million (with respect to the May 2024 Warrants, based on the Bank of Canada conversion rate as of May 28, 2025 of C$1.38 per US$1.00). We currently intend to use the proceeds, if any, received from any exercise of Warrants for investments in businesses and/or to fund any potential future acquisitions and for working capital and general corporate purposes, which may include the repayment of indebtedness. No assurances can be given that any such Warrants will be exercised.

The Selling Securityholders will pay any underwriting fees,